Literature DB >> 1094030

Human pituitary gonadotropin index. I. Standardized LRH test criteria for evaluation of functional amenorrhea.

E Keller, H G Dahlén, E Friedrich, H G Bohnet, R Richter, E W Joel, G Schubring, W Klemt, H I Wyss, A E Schindler, H P Schneider.   

Abstract

LRH test were carried out by giving 339 amenorrheic women and 74 normally menstruating volunteers an intravenous injection of 25 mug LRH (Hoe 471). Plasma LH and FSH were measured by RIA in two laboratories (Tuebingen and Ulm) using two standard reference preparations: LER 907 and 2nd IRP-HMG. The average conversion factors between the two standard preparations were calculated at 5.0 for LH and 25.0 for FSH. Furthermore, the estradiol-17beta levels were measured in 139 out of the 339 patients immediately before and 60 minutes after LRH injection. Taking the episodic and cyclic plasma gonadotropin fluctuations into consideration a shorthand system classifying the gonadotropin baseline (BI-BIV) and LH responses to 25 mug LRH (R0-R2) has been established and is referred to as Human Pituitary Gonadotropin Index (HPGI). It is possible to achieve reproducible gonadotropin results in two different laboratories using two different standard reference preparations. Two separate, randomly selected groups of amenorrheic women were found to have the same percent distribution of the HPGI. A correlation coefficient of r equal 0.67 between basal and LRH stimulated plasma LH levels does not sufficiently characterize the individual LH response behavior. A significant increase of plasma LH and FSH within the test period (60') reveals that the iv administration of 25 mug LRH represents an adequate dose for the LRH test in women. The HPGI which characterizes the functional state of gonadostat, may become a useful diagnostic index for evaluating women with anovulatory disease before, during, and after therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094030     DOI: 10.1210/jcem-40-6-959

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Hyperprolactinemia in anovulatory women. Incidence and endocrine features.

Authors:  A S Wolf; K Musch; C Lauritzen
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

2.  [Clinical endocrine investigations in patients with pituitary adenoma (author's transl)].

Authors:  D Mühlenstedt; J Hanker; H P Schneider
Journal:  Arch Gynakol       Date:  1978-07-19

3.  The biochemical investigation of the infertile couple.

Authors:  R R O'Moore
Journal:  Ir J Med Sci       Date:  1979-02       Impact factor: 1.568

4.  [Gonadoblastoma and overgrowing dysgerminoma in Turner mosaicism [45, XO/46, Xi (Xq)] (author's transl)].

Authors:  D Mühlenstedt; H G Bohnet; I H Pawlowitzki; H P Schneider
Journal:  Arch Gynecol       Date:  1979-03-28

5.  Diagnostic and therapeutic use of luteinizing hormone-releasing hormone (LH-RH).

Authors:  H P Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.